Virus-like particles (VLPs) are non-infectious nanoscale structures composed of viral proteins. They can be produced in various systems, functioning as delivery carriers of various bio- and nanomaterials. First identified in 1968, these particles self-assemble from viral structural proteins and are efficiently recognized by the immune system. They can be created experimentally using recombinant viral proteins.

Creative Biogene offers a state-of-the-art platform for high-quality VLPs production. Through our proprietary technology, we provide an array of VLPs and continue to innovate new types. Our platform promises efficient and reliable VLPs production, advancing not only current VLPs demand but also the development of novel VLP-based solutions.

Key Features of Our Virus-Like Particles

• Non-Infectious and Safe: Composed of viral proteins without genetic material, our VLPs are non-infectious, ensuring safety.
• Versatile Carriers: Produced in diverse systems, our VLPs serve as versatile carriers for delivering drugs, vaccines, and imaging agents.
• Efficient Self-Assembly: Our VLPs self-assemble from viral structural proteins, providing a natural and efficient formation process.
• Diverse Viral Sources: Derived from various viruses, including HIV, adeno-associated virus, Hepatitis B virus, Hepatitis C virus, and bacteriophages, our VLPs offer flexibility.
• Cutting-Edge Production Platform: Leveraging proprietary technology, Creative Biogene's platform ensures efficient, reliable, and innovative VLP production.